Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

UPEXI, INC. Director's Dealing 2022

Apr 1, 2022

33031_dirs_2022-04-01_94e7c57c-c463-4cb6-8766-88b044c511dc.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: GROVE, INC. (GRVI)
CIK: 0001775194
Period of Report: 2022-03-30-05:00

Reporting Person: Salkind Gene (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2022-03-30-05:00 Common Stock P 125000 $4.00 Acquired 125000 Indirect

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 2352942 Direct

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Option Grant $1.53 2031-02-21-05:00 Common (27778) 27778 Direct
Option Grant $4.18 2032-02-21-05:00 Common (50000) 50000 Direct

Footnotes

F1: 125,000 shares were purchased at $4.00 per share in a private transaction through the Marital Trust GST subject U/W/O Leopold Salkind Gene Salkind, Trustee and considered indirect ownership of Gene Salkind

F2: 27,778 options are vested and shall be exercisable for a price of $1.53 for 10 years from February 1, 2021 (the "Grant Date")

F3: 16,667 options are vested and shall be exercisable for a price of $4.18 for 10 years from July 21, 2022 (the "Grant Date"). 33,333 options share vest on a monthly basis over a two year period and exercisable for a price of $4.18 per option share for a ten year period of 10 years from the Grant Date.

F4: 2,352,941 previously purchased and are jointly owned with Catherine Salkind.